TP53 and carcinoma: Collectively, these data support the metastasis-associated transcriptomic signatures and further imply that p53R172H promotes the fitness and invasive properties of BRAFV600E-expressing organoids, which supports the assumption that TP53 mutations are important for the transition from adenoma to carcinoma [69, 70].